{ }
001122334455554433221100
001122334455554433221100

eli lilly acquires scorpion therapeutics for 2.5 billion in breast cancer push

Eli Lilly has announced a $2.5 billion acquisition of Scorpion Therapeutics’ PI3Kα pipeline, aiming to compete in the breast cancer market against Novartis and Roche. The deal includes the promising candidate STX-478, which has shown a 23% response rate in patients and is designed to selectively target mutant PI3Kα, potentially avoiding adverse effects seen with existing treatments. Lilly will also create a new company for Scorpion's non-PI3Kα assets, retaining Scorpion's staff.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.